PTSM: Pharmaceutical Technology Sourcing and Management, May 2, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, May 2, 2012
Biologics
White House Releases National Bioeconomy Blueprint
By Patricia Van Arnum
The Obama administration details five strategic imperatives to drive bioscience research as a means of economic growth.
Contract Services
CROs Urge for Modernization of Clinical Trials
By Patricia Van Arnum
Clinical research organizations see reform in clinical-trial process, including the establishment of chief innovation officer at FDA.
Outsourcing
Ways to Recover Lost Margins
By Gregg Brandyberry
Recovery audits and other past practices in procurement can improve the bottom line.
CSR and Sustainability Forum
The Marriage of Global Health and Sustainability
By Patricia Van Arnum
Industry leaders share their perspectives on how the pharmaceutical industry is and can further advance sustainability.
GlaxoSmithKline Outlines Its Sustainability Goals
By Patricia Van Arnum
The company provides progress made in 2011 and future environmental objectives.
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here